Skip to main content
. 2023 May 12;12:45. doi: 10.1186/s40164-023-00409-y

Fig. 2.

Fig. 2

Trial profile Allo-HSCT Allogeneic–hematopoietic stem-cell transplantation CR complete remission CRi complete remission with incomplete blood cell count recovery PR partial response NR no response